Adirondack Trust Company’s GoodRx Holdings GDRX Stock Holding History

Adirondack Trust Company’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$328	Hold	100	–	–	﹤0.01%	548
2026 Q2	$287	Hold	100	–	–	﹤0.01%	552
2026 Q1	$196	Hold	100	–	–	﹤0.01%	539
2025 Q4	$271	Hold	100	–	–	﹤0.01%	528
2025 Q3	$423	Hold	100	–	–	﹤0.01%	500
2025 Q2	$498	Buy	+100	New	+$434	﹤0.01%	469

Other funds holding GDRX

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

LWM

Lodestone Wealth Management Spokane, Washington $297M AUM 25.27% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Adirondack Trust Company's GDRX Position: Q3 2026 in Review

Adirondack Trust Company held its GoodRx Holdings (GDRX) position steady in Q3 2026 at 100 shares worth $328. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Adirondack Trust Company first reported a position in GDRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $498 in Q2 2025. 9 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

Adirondack Trust Company held 100 shares of GoodRx Holdings worth $328 as of Q3 2026.
Adirondack Trust Company left its GoodRx Holdings share count unchanged in Q3 2026.
GoodRx Holdings made up ﹤0.01% of Adirondack Trust Company's portfolio in Q3 2026, its #548 holding.
Adirondack Trust Company first reported a position in GoodRx Holdings in Q2 2025 and has held it in 6 quarters since.
Adirondack Trust Company's GoodRx Holdings position peaked at $498 in Q2 2025.
9 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Adirondack Trust Company's 13F filing for Q3 2026, filed 14 Oct 2026.